Immunic, Inc.
IMUX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001280776
No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Immunic, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 62 | 65 | +3 |
| Shares | 24.8M | 20.2M | −4.59M (−18.5%) |
| Value | $36.9M | $50.7M | +$13.8M (+37.2%) |
New holders (11)
Institutions that held Immunic, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 67,424 | $169.0K | 0.01% |
| Wolverine Trading, LLC | 18,150 | $41.7K | 0.00% |
| Two Sigma Securities, LLC | 14,346 | $36.0K | 0.00% |
| Jane Street Group, LLC | 13,157 | $33.0K | 0.00% |
| HRT Financial LP | 12,648 | $31.0K | 0.00% |
| Balboa Wealth Partners | 12,000 | $30.1K | 0.01% |
| LPL Financial LLC | 11,000 | $27.6K | 0.00% |
| Vontobel Holding Ltd. | 10,000 | $25.1K | 0.00% |
| Baader Bank INC | 11,262 | $21.9K | 0.00% |
| Caldwell Sutter Capital, Inc. | 5 | $13 | 0.00% |
| IFP Advisors, Inc | 2,000 | – | – |
Sold out (8)
Institutions that held Immunic, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Artal Group S.A. | 1,274,713 | $1.90M |
| Point72 Asset Management, L.P. | 714,655 | $1.06M |
| AWH Capital, L.P. | 500,000 | $745.0K |
| Marshall Wace, LLP | 134,459 | $200.3K |
| Barclays PLC | 68,740 | $102.4K |
| Goldman Sachs Group Inc | 33,571 | $50.0K |
| Prudential Financial Inc | 27,250 | $40.6K |
| Cetera Investment Advisers | 16,000 | $23.8K |